NDC 72426-818
Nexlizet 10 mg / 180 mg tablet, film coated
On the label: Esperion Therapeutics, Inc..
Where it's made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Esperion Therapeutics, Inc. names for other drugs.
Recalls
- Mar 27, 2024 · Class III · Esperion
Failed dissolution specifications: out-of-specification bempedoic acid dissolution at the 0-month timepoint.
Lots: Lot #, 1990305, Exp 08-31-2025 - Aug 16, 2023 · Class III · Esperion
Failed dissolution specifications: below specification results at stability 12-month
Lots: Lot# 1904872, Exp 1/31/2025; 1950377, Exp 6/30/2025
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Bempedoic Acid and Ezetimibe: every company that makes it
- Form
- tablet, film coated, oral
- Strength
- 10 mg / 180 mg
- Approval
- NDA NDA211617
- On the market since
- Mar 9, 2020
- Package NDCs
72426-818-0372426-818-0972426-818-99- Official label
- DailyMed (National Library of Medicine), updated Jun 25, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?